A new risk calculator to predict changes in IPSS score and risk of AUR / BPH-related surgery in BPH patients with moderate-severe symptoms at risk of disease progression receiving placebo, dutasteride, tamsulosin, or combination therapy
Gravas, S., Palacios, J.M., Thompson, D., Concas, F., Kamola, P.J., Roehrborn, C.G., Oelke, M., Kattan, M., Averbeck, M.A., Manyak, M., Lulic, Z.
Published in European urology (01.06.2021)
Published in European urology (01.06.2021)
Get full text
Journal Article